This brand name is authorized in Nigeria.
The drug SULFACAN contains one active pharmaceutical ingredient (API):
1
|
UNII
70FD1KFU70 - SULFUR
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-2482 | Cream | Sulfacan Cream CREAM 10% 12 x 30 g (in Lami tube) | Ointment Pale yellow solid homogenous ointment and very smooth when applied to the skin 127 CMS-PP-305591 SULFACAN CREAM PRECIPITATED SULFUR USP 10 % W/W Each gm of cream contains Sulfur precipitated USP (10% w/w) 100mg Anhydrous lanoline BP 2.5mg Cetostearyl Alcohol BP 25mg Hard Paraffin BP 140mg Micro crystalline wax USP 160mg Chlorocresol 1mg Liquid Paraffin (Light) BP 255mg Liquid Paraffin (Light) BP 220mg Liquid Paraffin (Light) BP 81.5 mg Fragrance (Rose Crystal) 10 mg A4-2482 Drugs Nigerian Products 1230g OTC 12/20/2022 SAGAR VITACEUTICALS NIGERIA LTD., PLOT 2, LADIPO OLUWOLE STREET 9022977711 suptpharm@svnl.in Sagar Vitaceuticals Nigeria Limited, Plot 2, Ladipo Oluwole Street, Off Oba Akran Avenue, Ikeja, Lagos, Nigeria, Nigeria | 21/12/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D10AB02 | Sulfur | D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AB Preparations containing sulfur |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-2482 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.